KalVista Pharmaceuticals, Inc.
Develops oral therapies for rare diseases, with a primary focus on HAE.
KALV | US
Overview
Corporate Details
- ISIN(s):
- US4834971032
- LEI:
- Country:
- United States of America
- Address:
- 200 CROSSING BOULEVARD, 1702 FRAMINGHAM
- Website:
- https://www.kalvista.com/
- Sector:
- Manufacturing
Description
KalVista Pharmaceuticals, Inc. is a biopharmaceutical company that discovers, develops, and commercializes oral therapies for rare diseases. The company specializes in small molecule protease inhibitors, with a primary focus on hereditary angioedema (HAE). Leveraging deep expertise in the plasma kallikrein-kinin system, KalVista has developed the first and only oral, on-demand treatment for HAE attacks. The company's mission is to elevate the standard of care and address significant unmet medical needs for patients by providing innovative, orally-delivered medicines.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all KalVista Pharmaceuticals, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for KalVista Pharmaceuticals, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for KalVista Pharmaceuticals, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
